Seminar Series and Events
Purdue Autism Research Center 2020 Conference
Friday, April 24, 2020
8:00 am-7:00 pm
Stewart Center, 128 Memorial Mall, West Lafayette, IN 47907
Attendees: $40 & Students: $20
Register here: http://www.conf.purdue.edu/Autism2020
The conference will include a series of keynote and symposia sessions by researchers in diverse fields related to autism spectrum disorder (ASD), ranging from basic to applied sciences. Featured keynote speakers for 2020 are Dr. Helen Tager-Flusberg, an expert in communication and social aspects of ASD, & Karen Pierce, an expert on the neural and clinical phenotype of ASD.
Autism Primer and ADOS Training
The Purdue Autism Research Center and Department of Psychological Sciences are co-sponsoring campus-wide trainings in autism assessment, in part through funding from the Discovery Park Big Ideas Challenge. Trainings will be facilitated by Dr. Becca McNally, Certified Independent ADOS-2 trainer and faculty member at IU School of Medicine, with support from Purdue University.
Conducting Autism Research: A Primer for Newbies: This one-hour workshop will provide a brief overview of topics relevant to researchers interested in entering the field of autism. The workshop will be facilitated by Drs. Becca McNally (IUSM), Bridgette Kelleher (HHS), and Mandy Rispoli (EDU); as well as Meagan Carrero, a parent of a child on the spectrum. The primer will include details on conceptualizing autism, understanding standardized practices for diagnostic phenotyping for research including selecting and interpreting measures, and respecting culture and priorities of the autism community. This training is open to faculty, postdocs, students (graduate and undergraduate), and research staff. The workshop will take place on Thursday, February 20th from 1:30-2:30 in LYLE 1160. There is also an option of attending the workshop online via Webex. If you plan on using this option we ask that you still RSVP using the link below. You can login to Webex, click on Webex trainings at the top of your screen, enter the session number: 644 856 915, then click 'join now' and enter password xV3CSuGE
Please RSVP at the following link: https://purdue.ca1.qualtrics.com/jfe/form/SV_3f3AgEju3wpTu7z
ADOS-2 Training: The Autism Diagnostic Observation Schedule (ADOS-2) is the gold-standard behavioral assessment of autism symptoms and is frequently used in both clinical and research settings.
- ADOS-2 Clinical Training is a two-day workshop facilitated by a certified trainer. Participants learn how to use the ADOS-2 to assess and diagnose autism through both didactic teaching on autism and the ADOS-2, as well as experiential teaching in which the leader demonstrates ADOS-2 administration and together the group practices ADOS-2 scoring. This training is open to anyone on campus (including folks who do not work with humans) who want to gain a deeper understanding of autism symptoms and diagnosis. For example, researchers interested in autism who have not previously conducted autism research are welcome to attend. Faculty, students, and staff are welcome.
This training will be held on March 28th & 29th in Morgan 121. Attendance is required both days. If you would like to attend please RSVP here: https://purdue.ca1.qualtrics.com/jfe/form/SV_38bageSETancuIR
- ADOS-2 Research Reliability Training is a two-day workshop open to folks who (1) have completed clinical training, which can be satisfied with the training above, and (2) are actively conducting research and/or clinical work relevant to autism, with priority for current researchers. Please note that seats for this training are very limited, and attendees will be expected to submit videos of their ADOS administrations to obtain reliability (at a cost of up to $500 per tape, to be paid by the trainee and/or lab) within 3 months of the training. This training is not appropriate for individuals with limited direct experience in interacting with individuals with autism.
Thank you to Discovery Park and the Department of Psychological Sciences for supporting these important initiatives. We hope you can join us.
Spring 2020 Lab presentations
- Friday, February 21, 2020
Uzay Emir, PhD
Assistant Professor, School of Health Sciences
- Friday, March 27, 2020
Carolyn McCormick, PhD
Assistant Professor, School of Health & Human Sciences
- Friday, April 17, 2020
Yang Yang, PhD
Assistant Professor, Medicinal Chemistry & Molecular Pharmacology
Spring Seminar Series (3/28/19)
Thursday, March 28, 2019
Purdue Autism Research Conference
October 18, 2018
Join researchers, students, and community members at the Purdue Autism Research Conference (PARC) to learn more about current research in diverse fields related to autism, ranging from basic to applied sciences. The daylong conference features keynote speakers Dr. Connie Kasari, an expert in social and communication interventions for children with autism, and Dr. David Amaral, an expert in biomedical and neural characteristics of autism.
Autism and Inclusion: Building School Communities that Support All Learners (4/5/2018)
Thursday, April 5, 2018
Purdue University, Lawson Hall, rm 1142
Project DATA: Collaborating at school to meet the needs of young children with ASD (4/6/2018)
Friday, April 6, 2018
Beering Hall, rm 1248
Elizabeth M. Berry-Kravis, Thursday (10/6/2017) 4:00pm, MJIS 1001
Professor Elizabeth M. Berry-Kravis
Departments of Pediatrics, Neurology, and Biochemistry, Rush University Medical Center
Abstract: The talk will describe the clinical characteristics of fragile X syndrome, basic research and animal model work leading to understanding of the roles of FMRP in regulation of dendritic translation and synaptic morphology and plasticity, and aberrant regulation ensuing from absence of FMRP in FXS and FXS models. The development of treatments correcting the cellular translational pathway, synaptic functioning and numerous phenotypes in the animal models will be presented, followed by a discussion of the effort to bring these findings to humans with FXS, including hurdles, lessons learned, and resultant need to develop new paradigms for translation of treatments targeted to mechanisms of neural plasticity in neurodevelopmental disorders.
Elizabeth M. Berry-Kravis, MD, PhD is a professor of pediatrics, neurology, and biochemistry at Rush University Medical Center. She received a Bachelor's degree in chemistry from the University of Notre Dame in 1979, a PhD in biochemistry in 1983 and MD in 1985 from the University of Chicago. She completed a pediatrics residency in 1987 and pediatric neurology fellowship in 1990, also at the University of Chicago, and moved to Rush University Medical Center in 1992.
Dr. Berry-Kravis established the comprehensive Fragile X Clinic and Research Program at Rush in 1992, through which she provides care and support to over 400 patients with fragile X syndrome for management of neurological, medical, and behavioral and genetic issues. Her clinical research projects involve studies of epilepsy and psychopharmacology in fragile X, clinical trials of new promising medications in FXS and development of outcome measures and biomarkers for such trials in the FXS population. She is also involved in research to characterize neurological problems in fragile X-associated tremor/ataxia syndrome (FXTAS) and relate clinical and radiological findings to molecular measures in fragile X carriers. Her laboratory research involves studies of effects of fragile X mental retardation protein (FMRP) on signal transduction mechanisms in neural cells as well as molecular studies aimed at identifying genetic risks and genotype-phenotype relationships in neurological disorders, including Alzheimer’s disease, Parkinson’s disease, vascular dementia, congenital central hypoventilation syndrome and SIDS.
Robin Gabriels, Thursday (11/3/2017) 10:30-11:30am
Associate Professor Robin Gabriels
Departments of Psychiatry and Pediatrics, University of Colorado, Denver
Topics: Randomized clinical trial of therapeutic horseback riding for autism spectrum disorder (Project Number: 1R01NR012736-01) and ongoing human-animal interaction research in a specialty autism hospital unit
Robin Gabriels, Psy.D. is an Associate Professor (depts. of psychiatry and pediatrics at the University of Colorado Denver Anchutz Medical Campus and currently the PI on a 4-year project studying the Effects of Therapeutic Horseback Riding on Children and Adolescents with Autism (Project Number: 1R01NR012736-01). Dr. Gabriels is also the subcontract PI for a multi-site project funded by the Simons Foundation and Lurie Foundation with the aim to phenotype children with ASD admitted to autism specialty psychiatric hospital inpatient units. Dr. Gabriels established and is the Program Director of the Neuropsychiatric Special Care program, a psychiatric inpatient and day treatment unit for children with ASD and/or intellectual disabilities (ages 4 to 17) at Children’s Hospital Colorado. She has over 30 years of experience developing intervention programs along with assessing and treating a variety of pediatric and adult populations. Her clinical and research efforts have focused on the ASD population for the past 19 years. Dr. Gabriels is a certified Autism Diagnostic Observation Schedule trainer (including the ADOS-2) with the test authors, providing ADOS research reliability training for hospital and academic institutions across the United States. She has written many articles and book chapters on autism, and has lectured and conducted workshops on ASD, both nationally and internationally. She has published two edited books, Autism: From Research to Individualized Practice, (2002) Jessica Kingsley Publishers and Growing Up with Autism: Working with School-Age Children and Adolescents (2007) Guilford Press.